Skip to main content
Skip to Footer

American Journal of Psychiatry

  • Volume 173
  • Number 8
  • August 2016

Editorials

Clinical Case Conference

Perspectives in Global Mental Health

Reviews and Overviews

Publication date: 03 May 2016

Pages771–780

How should DSM criteria relate to the disorders they are designed to assess? To address this question empirically, the author examines how well DSM-5 symptomatic criteria for major depression capture the descriptions of clinical depression in the post-...

https://doi.org/10.1176/appi.ajp.2016.15121509

Articles

Publication date: 03 May 2016

Pages781–789

Objective: Adolescents who regularly use marijuana may be at heightened risk of developing subclinical and clinical psychotic symptoms. However, this association could be explained by reverse causation or other factors. To address these limitations, the ...

https://doi.org/10.1176/appi.ajp.2016.15070878

Publication date: 22 April 2016

Pages790–798

Objective: The authors assessed 1) the overall risk of death among cannabis users compared with nonusers and the extent to which psychosis affects excess mortality; 2) mortality among persons with psychotic disorders and the extent to which cannabis use ...

https://doi.org/10.1176/appi.ajp.2016.14050637

Publication date: 24 May 2016

Pages799–806

Objective: Cigarette smoking during pregnancy is a major public health problem leading to adverse health outcomes and neurodevelopmental abnormalities among offspring. Its prevalence in the United States and Europe is 12%–25%. This study examined the ...

https://doi.org/10.1176/appi.ajp.2016.15060800

Publication date: 03 May 2016

Pages807–815

Objective: Both preclinical studies and clinical trials have indicated that the combination of a selective serotonin reuptake inhibitor (SSRI) and a statin may have superior antidepressant effects compared with SSRI treatment alone. The authors sought to ...

https://doi.org/10.1176/appi.ajp.2016.15040463

Publication date: 04 March 2016

Pages827–835

Objective: The authors sought to evaluate the efficacy and safety of ABT-126, a selective α7 nicotinic receptor partial agonist, in stable patients with schizophrenia. Method: A 12-week, double-blind, placebo-controlled, parallel-group phase 2 study was ...

https://doi.org/10.1176/appi.ajp.2015.15010093

Letters to the Editor

Book Forum

APA Official Actions

Publication date: 01 August 2016

Pages845–852

The following is an edited version of the 2015 Report of the American Board of Psychiatry and Neurology, Inc. The full report can be obtained from the American Board of Psychiatry and Neurology (www.abpn.com).

https://doi.org/10.1176/appi.ajp.2016.1730801

Past Issues

View Issues Archive
No.11
View Issue
1 Nov 2024

Vol. 181 | No. 11

No.10
View Issue
1 Oct 2024

Vol. 181 | No. 10

No.9
View Issue
1 Sep 2024

Vol. 181 | No. 9

No.8
View Issue
1 Aug 2024

Vol. 181 | No. 8